Investing Kyverna Therapeutics stock plunges after $100 million share offering Dylan D. DavisDecember 17, 2025 Kyverna Therapeutics stock plunges after $100 million share offering Source link
BlueScope’s largest investor backs $9 billion takeover rejection BlueScope’s largest investor backs $9 billion takeover rejection Source link
Several top drugmakers to lower US prices for some drugs-sources Several top drugmakers to lower US prices for some drugs-sources Source link
Australia stocks higher at close of trade; S&P/ASX 200 up 0.47% Australia stocks higher at close of trade; S&P/ASX 200 up 0.47% Source link
